| Product Code: ETC6896845 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Cyprus continued to rely on imports of insulin glargine, with significant shipments coming from top exporters including Greece, Germany, Netherlands, Switzerland, and Vietnam. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained at a moderate level, indicating a competitive market landscape. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 10.34%, with a notable growth spurt of 13.05% from 2023 to 2024, underscoring the increasing demand and importance of insulin glargine in Cyprus.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cyprus Insulin Glargine Market Overview |
3.1 Cyprus Country Macro Economic Indicators |
3.2 Cyprus Insulin Glargine Market Revenues & Volume, 2021 & 2031F |
3.3 Cyprus Insulin Glargine Market - Industry Life Cycle |
3.4 Cyprus Insulin Glargine Market - Porter's Five Forces |
3.5 Cyprus Insulin Glargine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Cyprus Insulin Glargine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Cyprus Insulin Glargine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Cyprus Insulin Glargine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Cyprus Insulin Glargine Market Trends |
6 Cyprus Insulin Glargine Market, By Types |
6.1 Cyprus Insulin Glargine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Cyprus Insulin Glargine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Cyprus Insulin Glargine Market Revenues & Volume, By Single Dose Vial, 2021- 2031F |
6.1.4 Cyprus Insulin Glargine Market Revenues & Volume, By Pre-filled Syringe, 2021- 2031F |
6.2 Cyprus Insulin Glargine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Cyprus Insulin Glargine Market Revenues & Volume, By Treat Type 2 Diabetes, 2021- 2031F |
6.2.3 Cyprus Insulin Glargine Market Revenues & Volume, By Treat Type 1 Diabetes, 2021- 2031F |
6.3 Cyprus Insulin Glargine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Cyprus Insulin Glargine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Cyprus Insulin Glargine Market Revenues & Volume, By Online Sales, 2021- 2031F |
6.3.4 Cyprus Insulin Glargine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.5 Cyprus Insulin Glargine Market Revenues & Volume, By Others, 2021- 2031F |
7 Cyprus Insulin Glargine Market Import-Export Trade Statistics |
7.1 Cyprus Insulin Glargine Market Export to Major Countries |
7.2 Cyprus Insulin Glargine Market Imports from Major Countries |
8 Cyprus Insulin Glargine Market Key Performance Indicators |
9 Cyprus Insulin Glargine Market - Opportunity Assessment |
9.1 Cyprus Insulin Glargine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Cyprus Insulin Glargine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Cyprus Insulin Glargine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Cyprus Insulin Glargine Market - Competitive Landscape |
10.1 Cyprus Insulin Glargine Market Revenue Share, By Companies, 2024 |
10.2 Cyprus Insulin Glargine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |